CVE-2010-0876
Estado: ModificadaMedia (4.3)—
Unspecified vulnerability in the Life Sciences - Oracle Clinical Remote Data Capture Option component in Oracle Industry Product Suite 4.5.3 and 4.6 allows remote attackers to affect integrity, related to RDC Onsite.
CVSS
- Versión: 2.0
- Vector: AV:N/AC:M/Au:N/C:N/I:P/A:N
- Puntuación base: 4.3
Probabilidad de explotación (EPSS)
- Probabilidad de explotación en los próximos 30 días: 2.06%
- Percentil entre todas las CVEs puntuadas: 81
- Fecha de la puntuación: 6/10/2026
EPSS (Exploit Prediction Scoring System, de FIRST) estima la probabilidad de que una vulnerabilidad sea explotada en 30 días. Complementa a CVSS (impacto) y a CISA KEV (explotación confirmada).
Tecnologías afectadas (1)
CWE
- NVD-CWE-noinfo
Referencias
- http://www.oracle.com/technetwork/topics/security/cpuapr2010-099504.html
- http://www.securitytracker.com/id?1023872
- http://www.us-cert.gov/cas/techalerts/TA10-103B.html
- http://www.oracle.com/technetwork/topics/security/cpuapr2010-099504.html
- http://www.securitytracker.com/id?1023872
- http://www.us-cert.gov/cas/techalerts/TA10-103B.html
JSON original (NVD)
Mostrar
{
"id": "CVE-2010-0876",
"cveTags": [],
"metrics": {
"cvssMetricV2": [
{
"type": "Primary",
"source": "nvd@nist.gov",
"cvssData": {
"version": "2.0",
"baseScore": 4.3,
"accessVector": "NETWORK",
"vectorString": "AV:N/AC:M/Au:N/C:N/I:P/A:N",
"authentication": "NONE",
"integrityImpact": "PARTIAL",
"accessComplexity": "MEDIUM",
"availabilityImpact": "NONE",
"confidentialityImpact": "NONE"
},
"acInsufInfo": false,
"impactScore": 2.9,
"baseSeverity": "MEDIUM",
"obtainAllPrivilege": false,
"exploitabilityScore": 8.6,
"obtainUserPrivilege": false,
"obtainOtherPrivilege": false,
"userInteractionRequired": false
}
]
},
"affected": [
{
"source": "secalert_us@oracle.com",
"affectedData": [
{
"vendor": "n/a",
"product": "n/a",
"versions": [
{
"status": "affected",
"version": "n/a"
}
]
}
]
}
],
"published": "2010-04-13T22:30:01.087",
"references": [
{
"url": "http://www.oracle.com/technetwork/topics/security/cpuapr2010-099504.html",
"source": "secalert_us@oracle.com"
},
{
"url": "http://www.securitytracker.com/id?1023872",
"source": "secalert_us@oracle.com"
},
{
"url": "http://www.us-cert.gov/cas/techalerts/TA10-103B.html",
"tags": [
"US Government Resource"
],
"source": "secalert_us@oracle.com"
},
{
"url": "http://www.oracle.com/technetwork/topics/security/cpuapr2010-099504.html",
"source": "af854a3a-2127-422b-91ae-364da2661108"
},
{
"url": "http://www.securitytracker.com/id?1023872",
"source": "af854a3a-2127-422b-91ae-364da2661108"
},
{
"url": "http://www.us-cert.gov/cas/techalerts/TA10-103B.html",
"tags": [
"US Government Resource"
],
"source": "af854a3a-2127-422b-91ae-364da2661108"
}
],
"vulnStatus": "Modified",
"weaknesses": [
{
"type": "Primary",
"source": "nvd@nist.gov",
"description": [
{
"lang": "en",
"value": "NVD-CWE-noinfo"
}
]
}
],
"descriptions": [
{
"lang": "en",
"value": "Unspecified vulnerability in the Life Sciences - Oracle Clinical Remote Data Capture Option component in Oracle Industry Product Suite 4.5.3 and 4.6 allows remote attackers to affect integrity, related to RDC Onsite."
},
{
"lang": "es",
"value": "Vulnerabilidad no especificada en el componente Life Sciences - Oracle Clinical Remote Data Capture Option en Oracle Industry Product Suite v4.5.3 y v4.6 permite a atacantes remotos afectar a la integridad, relacionado con RDC Onsite."
}
],
"lastModified": "2026-06-16T23:17:02.183",
"configurations": [
{
"nodes": [
{
"negate": false,
"cpeMatch": [
{
"criteria": "cpe:2.3:a:oracle:industry_product_suite:4.5.3:*:*:*:*:*:*:*",
"vulnerable": true,
"matchCriteriaId": "618E22C5-9DF5-4856-9D6F-CBBC72411842"
},
{
"criteria": "cpe:2.3:a:oracle:industry_product_suite:4.6:*:*:*:*:*:*:*",
"vulnerable": true,
"matchCriteriaId": "8ECA4CA7-A414-4022-89B4-7C6042DAF14D"
}
],
"operator": "OR"
}
]
}
],
"sourceIdentifier": "secalert_us@oracle.com"
}